Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LDHA | P00338 | 1/20 | 0.38 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.38 |
| ▸ | GRIK1 | P39086 | 3/20 | 0.38 |
| ▸ | GRIK2 | Q13002 | 3/20 | 0.38 |
| ▸ | GRM1 | Q13255 | 2/20 | 0.38 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.38 |
| ▸ | GRM8 | O00222 | 1/20 | 0.36 |
| ▸ | GRM6 | O15303 | 1/20 | 0.36 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.36 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.36 |
| ▸ | GSR | P00390 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | GRM5 | P41594 | 1/20 | 0.36 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.36 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.36 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.36 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.36 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.36 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.36 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1468654 | 1.00 | LDHA (0.38) | LDHASRRGRIK1GRIK2GRM1 | |
| SCHEMBL5321730 | 0.83 | ALOX15 (0.38) | GRIK1GRIK2GRM1GRM2GRM8 | |
| SCHEMBL5321722 | 0.83 | ALOX15 (0.38) | GRIK1GRIK2GRM1GRM2GRM8 | |
| Malonic Acid SCHEMBL9786773 | 0.78 | LDHA (0.56) | LDHASRRGRIK1GRIK2GRM1 | |
| SCHEMBL27718257 | 0.77 | — | — | |
| SCHEMBL865855 | 0.75 | — | — | |
| SCHEMBL25661405 | 0.75 | — | — | |
| SCHEMBL865856 | 0.75 | — | — | |
| SCHEMBL22728604 | 0.74 | LDHA (0.42) | LDHASRRGRIK1GRIK2GRM1 | |
| SCHEMBL7033320 | 0.74 | LDHA (0.42) | LDHASRRGRIK1GRIK2GRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9416248-B2 | Molasses binder | KNAUF INSULATION, INC. (US) | 2016-08-16 | — | — | US | disclosed |
| US-20150065646-A1 | MOLASSES BINDER | KNAUF INSULATION, INC. | 2015-03-05 | — | — | US | disclosed |
| CN-101378820-B | Molded filter | PSI GLOBAL LTD | 2012-07-04 | — | — | CN | disclosed |
| CN-102449218-A | Soft fiber insulation product | OWENS CORNING INTELLECTUAL CAP | 2012-05-09 | — | — | CN | disclosed |
| US-20110071101-A1 | Nucleoside Phosphonate Analogs | BOOJAMRA CONSTANTINE G | 2011-03-24 | — | — | US | disclosed |
| CN-101378820-A | Molded filter | PSI GLOBAL LTD (GB) | 2009-03-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110071101-A1 | Nucleoside Phosphonate Analogs | TYMP, PNP, NUDT1 | LDHA 1474/4885SRR 2217/4885GRIK1 3521/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.